Clinical Trial Detail

NCT ID NCT03154294
Title Evaluation of the Safety and Tolerability of TAK-228 With TAK-117 and Paclitaxel in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Avera McKennan Hospital & University Health Center
Indications

Advanced Solid Tumor

Therapies

MLN1117 + Paclitaxel + Sapanisertib

Age Groups: adult senior

No variant requirements are available.